Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin

This publication has 55 references indexed in Scilit:

• Elk-1 a Transcription Factor with Multiple Facets in the Brain
  Frontiers in Neuroscience, 2011
• Role of SUMO:SIM-mediated protein–protein interaction in non-homologous end joining
  Oncogene, 2010
• The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome
  Blood, 2010
• Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
  The Oncologist, 2010
• Sumoylation of Transcription Factor Tec1 Regulates Signaling of Mitogen-Activated Protein Kinase Pathways in Yeast
  PLOS ONE, 2009
• Origin and function of ubiquitin-like proteins
  Nature, 2009
• Common variants in the UBC9 gene encoding the SUMO‐conjugating enzyme are associated with breast tumor grade
  International Journal of Cancer, 2009
• Sorafenib in Advanced Hepatocellular Carcinoma
  New England Journal of Medicine, 2008
• The type I TGF-β receptor is covalently modified and regulated by sumoylation
  Nature Cell Biology, 2008
• Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance
  Advances in Enzyme Regulation, 2007